Faron Pharmaceuticals Oy (AIM: FARN)

Faron Pharmaceuticals Oy Statistics

Total Valuation

Faron Pharmaceuticals Oy has a market cap or net worth of GBP 154.32 million. The enterprise value is 139.69 million.

Market Cap	154.32M
Enterprise Value	139.69M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Faron Pharmaceuticals Oy has 104.62 million shares outstanding. The number of shares has increased by 14.45% in one year.

Current Share Class	n/a
Shares Outstanding	104.62M
Shares Change (YoY)	+14.45%
Shares Change (QoQ)	+4.96%
Owned by Insiders (%)	24.28%
Owned by Institutions (%)	9.61%
Float	73.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	132.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.21
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 9.23.

Current Ratio	1.45
Quick Ratio	1.28
Debt / Equity	9.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.00%
Return on Capital (ROIC)	-186.82%
Revenue Per Employee	n/a
Profits Per Employee	-788,198
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-33.00%
50-Day Moving Average	192.61
200-Day Moving Average	153.90
Relative Strength Index (RSI)	28.75
Average Volume (20 Days)	13,563

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.93M
Pretax Income	-26.76M
Net Income	-26.80M
EBITDA	-22.78M
EBIT	-22.93M
Earnings Per Share (EPS)	-0.39

Balance Sheet

The company has 25.42 million in cash and 10.79 million in debt, giving a net cash position of 14.63 million or 0.14 per share.

Cash & Cash Equivalents	25.42M
Total Debt	10.79M
Net Cash	14.63M
Net Cash Per Share	0.14
Equity (Book Value)	1.17M
Book Value Per Share	0.01
Working Capital	8.88M

Cash Flow

Operating Cash Flow	-17.09M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Faron Pharmaceuticals Oy does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.45%
Shareholder Yield	-14.45%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a